Skip to content

1 Week Crossover Study Between Two Soft Contact Lenses

1 Week Crossover Dispensing Study: Buttermere Versus MiSight 1 Day Soft Contact Lenses

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06611410
Enrollment
10
Registered
2024-09-25
Start date
2024-06-05
Completion date
2024-07-26
Last updated
2025-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Brief summary

The objective of this investigation is to compare the visual clinical performance of two daily disposable soft contact lenses.

Detailed description

This is a prospective, multiple day, double (investigator and subject) masked, randomized, bilateral crossover study comparing a Test lens against an appropriate Control lens. Main aim is to compare visual acuity and subjective vision ratings of vision quality between two lenses in habitual soft lens wearers.

Interventions

Daily disposable, soft contact lenses worn for one week.

Daily disposable, soft contact lenses worn for one week.

Sponsors

CooperVision, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
8 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* Are 8 to 18 years of age (inclusively) * Have read, signed and dated: * Age 18 - The Participant Informed Consent Form (participant only) * Age 12-17 - The Parental Permission Form (participant and parent) * Age 8-11 - The Parental Permission Form (parent) and Assent form (participant) * Are willing and able to follow instructions and maintain the appointment schedule. * Are habitual daily wearers of spherical single vision soft contact lenses to correct for distance vision in each eye, including myopia control soft contact lenses as below- * Currently wears spherical soft contact lenses or myopia control soft contact lenses. * Have a pair of wearable back-up spectacles. * Are willing and able to wear contact lenses for at least 10 hours a day, 6 days a week while in the study. * Are myopic with subjective refraction: -0.75D to -7.00D spherical, with an astigmatism ≤ -0.75D in each eye with maximum spherical equivalent anisometropia of 1.00D * Are correctable to a visual acuity of +0.10 logMAR or better (in each eye) with sphero-cylindrical subjective refraction. * Have clear corneas with no corneal scars or any active ocular disease. * Can be fit with the study contact lenses with a power between -0.75 and -7.00 DS; this translates to best corrected vision sphere refraction that vertexes to a CL power between -0.75 and -7.00 (inclusive) at screening visit. * Demonstrate an acceptable fit with the study contact lenses. * Demonstrate that they can safely and independently insert and remove contact lenses at the screening/fitting visit.

Exclusion criteria

* Have taken part in another clinical research study within the last 14 days. * Are currently habitual wearers of toric contact lenses. * Have worn any rigid contact lenses or ortho-keratology contact lenses in the past 30 days. * Are an extended contact lens wearer (i.e., sleeping with their contact lenses). * Are on ongoing atropine treatment for myopia control. * Have a difference of \> 1.0 D in best vision sphere subjective refraction between eyes. * Have amblyopia and/or strabismus/binocular vision problem. * Have any known active ocular disease, allergies and/or infection. * Have a systemic condition that in the opinion of the investigator may affect a study outcome variable. * Are using any systemic or topical medications that in the opinion of the investigator may affect a study outcome variable. * Have a known sensitivity to the diagnostic pharmaceuticals to be used in the study. * Have undergone refractive error surgery or intraocular surgery. * Are a member of CORL directly involved in the study.

Design outcomes

Primary

MeasureTime frameDescription
High Contrast, Binocular, Distance Visual Acuity (logMAR)At the end of one week wearHigh contrast, binocular, distance visual acuity (logMAR) will be measured at 1-week visit.

Secondary

MeasureTime frameDescription
Subjective Vision QualityAt the end of one week wearSubjective vision quality on 0-100 Visual Analog Scale (where, 0=very poor and 100=very good)

Countries

United States

Participant flow

Pre-assignment details

Ten participants were enrolled in the study. One participant was excluded due to screening failure. (n=9)

Participants by arm

ArmCount
Overall Study
Total eight participants were analyzed who completed all study visits. (One participant was excluded from the analysis due to protocol deviation)
8
Total8

Baseline characteristics

CharacteristicOverall Study
Age, Categorical
<=18 years
8 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
0 Participants
Race and Ethnicity Not Collected— Participants
Sex: Female, Male
Female
6 Participants
Sex: Female, Male
Male
2 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 90 / 9
other
Total, other adverse events
1 / 91 / 9
serious
Total, serious adverse events
0 / 90 / 9

Outcome results

Primary

High Contrast, Binocular, Distance Visual Acuity (logMAR)

High contrast, binocular, distance visual acuity (logMAR) will be measured at 1-week visit.

Time frame: At the end of one week wear

Population: Analysis population includes all the participants who completed all the study visits.

ArmMeasureValue (MEAN)Dispersion
Test Lenses (Stenfilcon A)High Contrast, Binocular, Distance Visual Acuity (logMAR)-0.15 logMARStandard Deviation 0.03
Control Lenses (Omafilcon A)High Contrast, Binocular, Distance Visual Acuity (logMAR)-0.15 logMARStandard Deviation 0.05
Secondary

Subjective Vision Quality

Subjective vision quality on 0-100 Visual Analog Scale (where, 0=very poor and 100=very good)

Time frame: At the end of one week wear

ArmMeasureValue (MEAN)Dispersion
Test Lenses (Stenfilcon A)Subjective Vision Quality94.12 units on a scaleStandard Deviation 4.67
Control Lenses (Omafilcon A)Subjective Vision Quality87.12 units on a scaleStandard Deviation 11.61

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026